Johnson & Johnson Reaches Deal With Trump Administration to Lower Drug Prices

Core Viewpoint - The agreement allows Johnson & Johnson's pharmaceutical products to be exempt from tariffs, which may positively impact the company's cost structure and pricing strategy [1] Group 1 - Johnson & Johnson's pharmaceutical products will benefit from tariff exemptions under the new agreement [1]